symplr Earns U.S. Best Managed Company Designation for Second Consecutive Year
Award highlights symplr's culture, operational excellence & innovation with symplr Operations Platform
HOUSTON, May 14, 2025 /PRNewswire/ -- symplr®, a leading provider of enterprise healthcare operations software, announced today it has been named a U.S. Best Managed Company for the second year in a row. Sponsored by Deloitte and The Wall Street Journal, the program recognizes outstanding U.S. private companies.
symplr was recognized for demonstrating excellence in strategic planning and execution, a deep commitment to employees, and maintaining strong financial performance and governance. The company propelled business growth while prioritizing employees and delivering exceptional value to customers. By leveraging advanced technology, including AI, symplr achieved significant efficiencies and enhanced the quality of its products and customer experiences.
"2025 has already been a pivotal year for symplr as we focus on solving some of healthcare's most complex operational challenges through the newly launched symplr Operations Platform," said Hugo Doetsch, Chief Financial Officer at symplr. "It's an honor to be part of an elite group named a U.S. Best Managed Company as a testament to the dedication of our team and the meaningful impact we're making to transform the industry."
Applicants are evaluated and selected by a panel of external judges focused on assessing hallmarks of excellence in four key areas: strategy, ability to execute, corporate culture, and governance/financial performance. They join a global ecosystem of honorees from more than 44 countries recognized by the Best Managed Companies program.
Hear from symplr's CEO, BJ Schaknowski, on what this recognition means for the company, its employees, and the future of healthcare operations at www.symplr.com/us-best-managed-company.
About symplr symplr is a leader in enterprise healthcare operations software and services with a first-of-its-kind operations platform. Trusted in 9 of 10 U.S. hospitals and 400+ U.S. health plans, symplr optimizes operations and maximizes care powered by our cloud-based workforce, quality, provider data management, and spend solutions. Gain efficiency, reduce complexity, and improve outcomes where it matters most. Learn how to stay ahead of change at www.symplr.com.
About the Best Managed Companies ProgramThe Best Managed Companies program is a mark of excellence for private companies. U.S. designees have revenues of at least $250 million. Hundreds of private companies around the world have competed for this designation in their respective countries through a rigorous and independent process that evaluates four key criteria in their management skills and practices — strategy, execution, culture and governance/financials. U.S. program sponsors are Deloitte Private and The Wall Street Journal. For more information, visit www.usbestmanagedcompanies.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/symplr-earns-us-best-managed-company-designation-for-second-consecutive-year-302454840.html
SOURCE symplr
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Engineering the Perfect Shower Squeegee: The Story Behind dancemoon JustHang Squeegee
NEW YORK, June 7, 2025 /PRNewswire/ -- dancemoon, the trailblazer in home cleaning innovation, proudly introduced its first-ever bathroom cleaning tool: the JustHang Squeegee. Designed for effortless use and stylish storage, the product officially launched worldwide on June 3 via dancemoon's website and Amazon, debuting at a special launch price of $19.99. It has been well-received on social media for its outstanding performance and uniquely innovative built-in hook, and has continued to gain traction on Amazon and the official website since its initial launch. What sets the JustHang Squeegee apart is the thoughtful design, inspired by the simple and universal natural habit of hanging things up after use. Through rounds of real-life testing and countless small tweaks, the dancemoon team turned this everyday habit into a clean, minimalist solution that blends form and function. And behind this seemingly simple tool is a deliberate design process worth sharing. How It's Made: Integrated Molded Structure: The built-in hook of JustHang Squeegee isn't a traditional after-assembly attachment. Instead, it is molded by one-piece injection molding. This process reduces breakage risk at joints, maintains minimalist lines and structural stability, prevents dirt buildup and avoids discoloration over time. The handle uses glass fiber reinforced PA66 and the scraper blade is made of hardened 45 steel, offering excellent strength and heat resistance, enabling JustHang Squeegee to withstand up to 75kg pressure without breaking. Size and Angle Validation: Based on user habit research, dancemoon designers analyzed common hanging points and user behaviors in the bathroom. Through multiple prototype tests and hanging simulations, the size and angle of the built-in hook were finely adjusted to ensure that it can be firmly fixed in places such as towel bars, glass doors and countertops, and perfectly fit the user's natural "use and hang" action. Premium Flexible Silicone: Made from high-elasticity 50 Shore A silicone, this material offers an ideal balance of flexibility and structural strength. After extensive durability testing, the dancemoon design team selected this specific hardness for its outstanding performance in wet and slippery environments, resisting deformation and cracking even with prolonged use. The result is a smoother, more efficient water-wiping experience and a significantly longer lifespan compared to traditional squeegees. Why JustHang Squeegee? Convenience: Effortless to hang anywhere even with wet hands. Versatility: Designed to fit seamlessly into various home settings, offering clean, clutter-free storage. Durability: One-piece molded construction minimizes breakage and lasts longer than traditional scrapers. To place an order, please visit dancemoon's Amazon store and Shopify. Or follow dancemoon on social media to stay updated with the latest campaigns for the new product: Instagram: Facebook: YouTube: About dancemoon Driven by a passion for innovative design, dancemoon infuses the beauty and emotion of the moon into each product. Beyond offering household tools, dancemoon combines innovation with minimalist design to create products that make household tasks simple and no longer a burden but an enjoyable part of life. With a vision to become the leading brand of minimalist lifestyle, dancemoon is committed to blending minimalism with household tools, bringing bliss into your daily life. CONTACT: info@ View original content to download multimedia: SOURCE dancemoon
Yahoo
a day ago
- Yahoo
Nucleus Genomics Launches Nucleus Embryo, Genetic Optimization Software Alongside Partnership with Genomic Prediction
Parents pursuing IVF now have a new level of choice to empower their family planning NEW YORK, June 4, 2025 /PRNewswire/ -- With U.S. birthrates plummeting and IVF on the rise, Nucleus Genomics today launched Nucleus Embryo, the first genetic optimization software that lets parents see and understand a complete genetic profile to select an embryo. "Before there's a heartbeat, there's DNA," said Kian Sadeghi, founder and CEO of Nucleus. "One file containing DNA and genetic markers can tell you more about your baby's future than any other test a doctor could possibly run at this stage. Most clinics stop at whether an embryo will develop. For many parents, that's not enough. Patients have long asked for more transparency from clinics, and Nucleus Embryo is an important step toward complete data ownership for parents planning their families." The software enables parents to analyze and compare up to 20 embryos across over 900 hereditary conditions and 40 additional analyses beyond basic viability, spanning cancers, chronic conditions, appearance, cognitive ability, mental health, and more. To widen access to the software, Nucleus will partner with Genomic Prediction, the first company to offer genome-wide screening on embryos. The partnership sets a new standard in genetic medicine, continuing Genomic Prediction's decade-long history of giving hopeful parents the best possible chance of implanting healthy embryos. The company's analyses focus on hereditary conditions, acting as the first line of defense against chronic and rare diseases. "As an organization, we are committed to supporting patients' rights to their DNA and any information that can aid in their family-building journey," said Kelly Ketterson, CEO of Genomic Prediction. "We have a legacy of innovation aimed at providing patients with access to the best scientific resources. Our partnership with Nucleus opens access to information our patients have requested and allows us to uphold our commitment to this legacy." Nucleus' partnership with Genomic Prediction reflects a growing shift in how parents think about genetics as a tool to give children the best possible start in life. A wide-ranging study of Americans found the majority accepted the use of genetic technology to choose embryos based on health and personality traits. Four in 10 parents would use genetic optimization as another tool to understand their future child's cognitive abilities. Most women undergo three to six IVF cycles before successfully having a baby, with each cycle costing up to $25,000. Many embryos are unviable within days of being fertilized, leaving parents with few to choose from. Facing high stakes, clinicians often recommend genetic testing to optimize a couple's chances of a healthy pregnancy. But these tests typically stop at a select number of hereditary conditions and chromosome count. Now, advanced genetic analysis from Nucleus gives parents a new window into the health and well-being of their future child. Nucleus Embryo provides a comprehensive genetic profile for each embryo, encompassing hereditary genetic diseases, like cystic fibrosis and hemochromatosis, alongside genetic measures of cognitive ability, mental health, and risk for chronic diseases. Wide access to genetic insights for embryos can also help extend lifespan from the earliest stages of life. While more than half of all deaths annually in the U.S. are attributed to chronic, age-related conditions — such as Alzheimer's disease, diabetes, cancer, and heart disease — research shows embryonic selection can materially help reduce disease risk for these conditions. "We celebrate health optimization and the pursuit of longevity in every other part of life via our focus on training, supplements, and sleep," Sadeghi said. "We all know health isn't just the absence of disease. It's the ability to understand our bodies and genetic makeup to reach our full potential. Now we can apply this principle to life's inception." About Nucleus Genomics Nucleus builds software for generational health. Inspired by the loss of his cousin who died of a rare — yet preventable — genetic disease, Nucleus founder and Thiel Fellow Kian Sadeghi left an Ivy League university to build a product that could have saved her life. Our advanced DNA health test and analysis takes the guesswork out of your health, whether it's perfecting your protocols, knowing your risk for cancer, or planning for a healthy family. Follow us on social media @nucleusgenomics. About Genomic Prediction Genomic Prediction, Inc. is the frontrunner in advanced embryo screening. Our proprietary LifeView platform is state-of-the-art technology that assesses embryos for genetic health aimed at improved IVF outcomes. The LifeView Embryo Health Score Test (EHS) offers insight into the likelihood of developing conditions driven by multiple genes. It tests for significant health issues, including cardiovascular disease, diabetes mellitus, certain cancers, and mental health conditions. The EHS results are derived from the same embryo sample used in the following PGT tests: PGT-A: Identifies chromosome abnormalities in embryos. PGT-A+: Pinpoints the origin (paternal, maternal, or embryonic) of chromosome abnormalities. PGT-M: Decreases the chances of passing on monogenic (single-gene) conditions. PGT-SR: Detects chromosome abnormalities and structural imbalances, providing clarity between normal and balanced chromosomes. View original content to download multimedia: SOURCE Nucleus
Yahoo
a day ago
- Yahoo
Musk and the Millers Got Cozy Outside the White House
During happier times at the White House, Elon Musk was known to spend large amounts of time with Stephen Miller and his wife, Katie, even outside of work. Katie Miller, an aide in the Department of Government Efficiency, was with Musk 'almost all the time' while he was at the White House, before opting to follow him out the door last month, The Wall Street Journal reports. Her departure is thought to have caused friction among White House officials. Miller was reportedly on Musk's payroll the entire time, even when her official role was as a special government employee, according to Politico's Playbook. 'And, like … who was she looking out for?' one unnamed administration official said. The idea that Stephen Miller, the White House deputy chief of staff, was a close companion of Musk now seems far-fetched. The two have since had a public falling-out after Musk condemned President Donald Trump's One Big Beautiful Bill Act as a 'pork-filled' spending bill and a 'disgusting abomination.' Miller, one of Trump's most loyal allies, fired back with a thinly veiled attack on Musk on X on Thursday, writing: 'The only 'new' spending in the bill is to defend the homeland and deport the illegals—paid for by raising visa fees. All the other provisions? Massive spending cuts. There is no 'pork' in the bill. Just campaign promises.' Musk unfollowed Stephen Miller on social media around the same time his attacked him online. The Journal highlighted the fallout between Musk and Miller as yet another example of Musk burning bridges and irritating allies during his stint in the White House. Of course, there was an even more explosive falling-out between Musk and another former close ally on Thursday. The simmering tensions between Musk and President Donald Trump reached boiling point with an extraordinary back-and-forth playing out on social media. Trump lashed out at Musk for opposing his One Big Beautiful Bill Act and accused him of going 'crazy' over his plans to eliminate the electric vehicle (EV) mandate implemented under the Biden administration. Trump also suggested that the quickest way to save billions in federal spending would be to terminate the government subsidies and contracts awarded to Musk's tech companies. Earlier in the day, Trump told reporters during an Oval Office meeting with German Chancellor Friedrich Merz that he believes Musk has 'TDS [Trump Derangement Syndrome].' Responding with a furious post, Musk claimed on X: 'Without me, Trump would have lost the election,' and reposted in agreement a call for the president to be impeached and replaced with JD Vance. He also warned that Trump's import tariffs would trigger a recession later this year. Musk then dropped a 'really big bomb' in the spiralling feud. 'Trump is in the Epstein files. That is the real reason they have not been made public,' Musk wrote. It is well known that Trump and billionaire child sex offender Jeffrey Epstein, who died by suicide in 2019, were at least acquaintances. Epstein partied with Trump at his Mar-a-Lago resort in the 1990s, and Trump flew on Epstein's private jet multiple times during that period. The two reportedly fell out around 2004 over a property dispute in Palm Beach, Florida. There is no evidence Trump was connected to or aware of Epstein's crimes. In a statement regarding the public falling-out, White House press secretary Karoline Leavitt said: 'This is an unfortunate episode from Elon, who is unhappy with the One Big Beautiful Bill because it does not include the policies he wanted.' 'The president is focused on passing this historic piece of legislation and making our country great again.'
